Culbertson A N Co Inc buys $5,864,797 stake in Varian Medical Systems (VAR)

Varian Medical Systems (VAR) : Culbertson A N Co Inc scooped up 90 additional shares in Varian Medical Systems during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Oct 12, 2016. The investment management firm now holds a total of 60,325 shares of Varian Medical Systems which is valued at $5,864,797.Varian Medical Systems makes up approximately 2.11% of Culbertson A N Co Inc’s portfolio.

Other Hedge Funds, Including , Atria Investments reduced its stake in VAR by selling 21 shares or 0.69% in the most recent quarter. The Hedge Fund company now holds 3,013 shares of VAR which is valued at $292,924. Varian Medical Systems makes up approx 0.03% of Atria Investments’s portfolio.Exxonmobil Investment Management Inc Tx reduced its stake in VAR by selling 802 shares or 3.25% in the most recent quarter. The Hedge Fund company now holds 23,844 shares of VAR which is valued at $2,361,033. Varian Medical Systems makes up approx 0.05% of Exxonmobil Investment Management Inc Tx’s portfolio. Simplex Trading added VAR to its portfolio by purchasing 2,067 company shares during the most recent quarter which is valued at $204,674. Varian Medical Systems makes up approx 0.03% of Simplex Trading’s portfolio.Bnp Paribas Arbitrage Sa reduced its stake in VAR by selling 26,701 shares or 79.51% in the most recent quarter. The Hedge Fund company now holds 6,880 shares of VAR which is valued at $681,877.

Varian Medical Systems closed down -1.69 points or -1.71% at $97.22 with 8,19,896 shares getting traded on Tuesday. Post opening the session at $98.63, the shares hit an intraday low of $96.59 and an intraday high of $98.74 and the price fluctuated in this range throughout the day.Shares ended Tuesday session in Red.

On the company’s financial health, Varian Medical Systems reported $1.22 EPS for the quarter, beating the analyst consensus estimate by $ 0.05 according to the earnings call on Jul 27, 2016. Analyst had a consensus of $1.17. The company had revenue of $789.40 million for the quarter, compared to analysts expectations of $782.00 million. The company’s revenue was up .7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.15 EPS.

Many Wall Street Analysts have commented on Varian Medical Systems. Company shares were Reiterated by Barrington Research on Jul 28, 2016 to “Outperform”, Firm has raised the Price Target to $ 102 from a previous price target of $93 .

Varian Medical Systems Inc. is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy radiosurgery proton therapy and brachytherapy. The Company is a supplier of X-ray imaging components for medical scientific and industrial applications and supplies X-ray imaging products for cargo screening and industrial inspection. The Company offers tools for fighting cancer taking X-ray images and protecting ports and borders. The Company’s products include linear accelerators brachytherapy afterloaders treatment simulation and verification equipment accessories information management treatment planning and image processing software. The Company’s customers include university research and community hospitals private and governmental institutions healthcare agencies doctors’ offices and cancer care clinics.

Leave a Reply

Varian Medical Systems - Is it time to Sell?

Top Brokerage Firms are advising their investors on Varian Medical Systems. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.